Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in Regeneron Lawsuit - REGN
Portfolio Pulse from
Levi & Korsinsky has announced a lead plaintiff deadline of March 10, 2025, for a lawsuit involving Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Shareholders who suffered losses may seek recovery under federal securities laws.
March 02, 2025 | 4:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a lawsuit with a lead plaintiff deadline of March 10, 2025. Shareholders who incurred losses may be eligible for recovery under federal securities laws.
The announcement of a lawsuit and the potential for shareholder recovery under federal securities laws could negatively impact Regeneron's stock price in the short term as it may lead to investor uncertainty and potential financial liabilities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100